Danazol for Treatment of Cytopenias in Patients With Cirrhosis (NCT04873102)
A Phase II Single Center Single Arm Pilot Study Administering Danazol for Treatment of Cytopenias in Patients With Cirrhosis
🩺 Plain-English Summary (8th-Grade Level)
This is a phase II pilot study designed to assess the safety and efficacy of danazol for treatment of cytopenias in patients with CPC A/B cirrhosis. Subjects with or without telomere mutations and/or shortened telomeres will be treated with danazol 600 mg per day by mouth for a duration of 24 months. The goal will be to treat a total of 10 patients.
Who can join: Review the eligibility criteria below.
Location: Keck Hosital of USC — Los Angeles, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Keck Hosital of USC — Los Angeles, California
📞 Contact the Study Coordinator
Phone: (323) 865-3000
Email: isyed@med.usc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cirrhosis, Liver
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study — Ann Arbor, Michigan
- ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement — Phoenix, Arizona
- Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease — Ann Arbor, Michigan
- Angiotensin 2 for AKI After OLT — Los Angeles, California
- Erlotinib for Hepatocellular Carcinoma Chemoprevention — Dallas, Texas
- Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics — Chandler, Arizona
Explore by condition: All Cirrhosis, Liver clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.